Approvals/TGA/NORADRENALINE KABI noradrenaline (norepinephrine) (as acid tartrate monohydrate) 4 mg/4 mL concentrated injection ampoule

Approved

STANDARD

NORADRENALINE KABI noradrenaline (norepinephrine) (as acid tartrate monohydrate) 4 mg/4 mL concentrated injection ampoule

Fresenius Kabi Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 6b2073a0105b3aaa
Product Name: NORADRENALINE KABI noradrenaline (norepinephrine) (as acid tartrate monohydrate) 4 mg/4 mL concentrated injection ampoule
Artg Id: 424894
Artg Name: NORADRENALINE KABI noradrenaline (norepinephrine) (as acid tartrate monohydrate) 4 mg/4 mL concentrated injection ampoule
Sponsor: Fresenius Kabi Australia Pty Ltd
Company Detail Path: /organization/fresenius-kabi-australia-pty-ltd
Artg Date: 2024-12-18
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/2569d1d6a6354ac0d8680a9920991a66.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/e220c3cd4be36135a80693760b1a9a17.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

6b2073a0105b3aaa

Type

Standard